Lee Ainslie's IART Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 72,108 shares of Integra LifeSciences Holdings Corporation (IART) worth $679,257, representing 0.01% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Lee Ainslie has maintained a strategic position in IART, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 72,108 shares. Largest reduction occurred in Q3 2021, reducing 15,292 shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's Integra LifeSciences Holdings Corporation (IART) Holding Value Over Time
Track share changes against reported price movement
Quarterly Integra LifeSciences Holdings Corporation (IART) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +72,108 | New Buy | 72,108 | $9.42 |
| Q2 2024 | -9,419 | Sold Out | 0 | $0.00 |
| Q1 2024 | +767 | Add 8.87% | 9,419 | $35.45 |
| Q4 2023 | +1,184 | Add 15.85% | 8,652 | $43.55 |
| Q3 2023 | -2,627 | Reduce 26.02% | 7,468 | $38.19 |
| Q2 2023 | -61 | Reduce 0.60% | 10,095 | $41.13 |
| Q1 2023 | +4,029 | Add 65.76% | 10,156 | $57.41 |
| Q4 2022 | +6,127 | New Buy | 6,127 | $56.07 |
| Q4 2021 | -7,007 | Sold Out | 0 | $0.00 |
| Q3 2021 | -15,292 | Reduce 68.58% | 7,007 | $68.50 |
| Q2 2021 | +12,447 | Add 126.34% | 22,299 | $68.25 |
| Q1 2021 | -3,254 | Reduce 24.83% | 9,852 | $69.12 |
| Q4 2020 | -7,786 | Reduce 37.27% | 13,106 | $64.93 |
| Q3 2020 | +20,892 | New Buy | 20,892 | $47.24 |
Lee Ainslie's Integra LifeSciences Holdings Corporation Investment FAQs
Lee Ainslie first purchased Integra LifeSciences Holdings Corporation (IART) in Q3 2020, acquiring 20,892 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held Integra LifeSciences Holdings Corporation (IART) for 14 quarters since Q3 2020.
Lee Ainslie's largest addition to Integra LifeSciences Holdings Corporation (IART) was in Q1 2026, adding 72,108 shares worth $679,257.
According to the latest 13F filing for Q1 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 72,108 shares of Integra LifeSciences Holdings Corporation (IART), valued at approximately $679,257.
As of the Q1 2026 filing, Integra LifeSciences Holdings Corporation (IART) represents approximately 0.01% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in Integra LifeSciences Holdings Corporation (IART) was 72,108 shares, as reported at the end of Q1 2026.